Back to EZorb Newsletter Index

EZorb

  

EZORB MONTHLY NEWSLETTER AUG 28, 2016

In this issue:

 

1. Share Success: Letters From Readers
2. Research News: Lower BP May Reduce CV Risk Of Diabetes
3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb and Marvlix?
  

1. Share Success: Letters From Readers 

***************************************************

Letter I: From Loretta M.

Received at Testimonial Submit Form Wednesday, June 01, 2016 at 13:59:31

(Unedited)

 

Hi, my name is Loretta M. It is about 3 years now I am using Ezorb.

I found Ezorb below a med that I went to read upon, on the internet, that my Dr. had prescribed for me. When I saw the deadly side effect, on the drug prescribed, I read upon the EZorb and Marvlix, which was listed below the other drug. (Good place to put it!)

I decided to try the Ezorb, for my bones, and energy. My Dr's asked me what am I doing, to make my skin so healthy looking. People wonder how I move around, so strong, and do gardening, Minister, very active in my community, healthy skin, hair and energetic.

When my Doctors asked me what I do for Calcium, I responded, I take EZorb! I am doing well.

I recommended EZorb to two People complaining of pain. I gave one lady 1 bottle of 180 and she says, It really helps, but she can't afford it. I just gave another Lady one bottle of 180. but she too, says it is too expensive for her.

EZorb is good. If I have cranky pains, I am reminded by the pain, to take my EZorb. I do take vitamins with this, and I am very happy with my health. I am 73 Yrs. Young, and enjoying my health.

I am a survivor of 8 years now, I am happy for life. I must have EZorb in my house to help my bones. I believe that - EZorb does all that it claims to do. Every person's body is different, but EZorb will help you along! It would be nice if EZorb, would give free bottles for starter kits, Good product! I would recommend EZorb for any person with lot of pain! it will help!


Letter II: From W/P. Albers

Received at Testimonial Submit Form Friday, January 22, 2016 at 03:21:15

(Unedited)

 

I started using Marvlix in September of 2013. At the time my Creatinine was 164 and my eGfr was at 38.

Today I am proud to say that using Marvlix along with a closely monitored diet my Creatinine is 1.2 and my eGfr is 62.


Letter III: From Susan B.

Received at Testimonial Submit Form Sunday, December 27, 2015 at 21:32:18

(Unedited)

 

I love Ezorb. I started taking Ezorb about 4 years ago because I was diagnosed with osteoporosis and did my own research.

Beforehand I took those dreadful drug my doctor wanted me take and now 5 year later I no longer osteoporosis!

I owe it to ezorb and following an alkaline diet. It took me a little longer than the average people, as you told me it would. I am an HIV victim. I've preached Ezorb for as long as I been taking Ezorb. So again thank you for such a great product.

Susan


From the Desk of EZorb Newsletter Editor:

 
This newsletter is now read by over 95,000 subscribers worldwide. Success stories you have contributed over the years have had a great impact on many people's quality of life. Your continuous support will be greatly appreciated by tens of thousands who have been suffering and would continuously suffer, without your help! Please email your story to sharesuccess @ ezorbonline.com or simply post it at Testimonial Submit Form. Your personal information will never be revealed to the public. If your testimonial is selected for publication, you will receive a generous gift to show our appreciation of your effort.


2. Research News: Lower BP May Reduce CV Risk Of Diabetes

 

Swedish researchers have shown that a lower-than-recommended systolic blood pressure (BP) is associated with a significantly reduced risk of cardiovascular (CV) events in patients with Type 2 diabetes.

The study of 187,106 patients with no previous CV events or other major disease, entered into the Swedish national diabetes register, revealed that patients with a systolic BP of 110-119 mmHg had a significant 12% lower risk of CV disease (acute myocardial infarction or stroke) than those with a systolic BP of 130-139 mmHg, which would meet the currently recommended goal.

The patients with the lowest blood pressure also had a 24% lower risk of non-fatal acute myocardial infarction, a 15% lower risk of acute myocardial infarction, an18% lower risk of non-fatal CV disease and a 12% lower risk of non-fatal coronary heart disease, compared with those in the 130-139 mmHg reference group.

In addition, Samuel Adamsson Eryd (Center of Registers Vastra Gotyaland, Gothenburg) and colleagues found no indication of a J-shaped relationship between these outcomes and systolic BP.

That is in spite of the fact that the target BP for patients with diabetes has recently been raised from below 130 mmHg to below 140 mmHg because of "a lack of conclusive randomized studies to support the lower goal, together with observational studies showing a J shaped relation between blood pressure and complications", the authors point out.

There was, however, a J-shaped relationship between systolic BP and both heart failure and total mortality, with patients in the lowest systolic BP group (110-119 mmHg) having significant 20% and 28% increased risks, respectively, compared with those in the reference group.

But Adamsson Eryd et al note that patients with the lowest blood pressure also received the least antihypertensive treatment.

"We cannot therefore draw any conclusions about harmful effects of intensive antihypertensive treatment", they write in The BMJ.

The researchers also found that when they included individuals with previous disease in a secondary analysis, the relationship between systolic BP and each of the outcomes studied became J-shaped.

"Accordingly, the J curve relation observed in real world data depends on patient selection and the extent to which comorbidity can be adjusted for", Adamsson Eryd and co-authors remark.

They conclude: "The association between low blood pressure and increased mortality could be due to concomitant disease rather than antihypertensive treatment."

Original research was published in BMJ 2016; 354: i4070 Diabetes News.


3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now

  

 

4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to test @ elixirindustry.com for a copy of the instructions.

 

 

5. What Are Others Saying About EZorb and Marvlix?

EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix.

Back to EZorb Newsletter Index

 
 
  Copyright 2016 Elixir Industry